Literature DB >> 34826253

MRI-based radiomics model can improve the predictive performance of postlaminar optic nerve invasion in retinoblastoma.

Zhenzhen Li1,2, Jian Guo1,2, Xiaolin Xu2,3, Wenbin Wei2,3, Junfang Xian1,2.   

Abstract

OBJECTIVES: To develop an MRI-based radiomics model to predict postlaminar optic nerve invasion (PLONI) in retinoblastoma (RB) and compare its predictive performance with subjective radiologists' assessment.
METHODS: We retrospectively enrolled 124 patients with pathologically proven RB (90 in training set and 34 in validation set) who had MRI scans before surgery. A radiomics model for predicting PLONI was developed by extracting quantitative imaging features from axial T2W images and contrast-enhanced T1W images in the training set. The Kruskal-Wallis test, least absolute shrinkage and selection operator regression, and recursive feature elimination were used for feature selection, where upon a radiomics model was built with a logistic regression (LR) classifier. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve and the accuracy were assessed to evaluate the predictive performance in the training and validation set. The performance of the radiomics model was compared to radiologists' assessment by DeLong test.
RESULTS: The AUC of the radiomics model for the prediction of PLONI was 0.928 in the training set and 0.841 in the validation set. Radiomics model produced better sensitivity than radiologists' assessment (81.1% vs  43.2% in training set, 82.4vs 52.9% in validation set). In all 124 patients, the AUC of the radiomics model was 0.897, while that of radiologists' assessment was 0.674 (p < 0.001, DeLong test).
CONCLUSION: MRI-based radiomics model to predict PLONI in RB patients was shown to be superior to visual assessment with improved sensitivity and AUC, and may serve as a potential tool to guide personalized treatment.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34826253      PMCID: PMC8822570          DOI: 10.1259/bjr.20211027

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  39 in total

1.  Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution.

Authors:  F Khelfaoui; P Validire; A Auperin; E Quintana; J Michon; H Pacquement; L Desjardins; B Asselain; P Schlienger; P Vielh
Journal:  Cancer       Date:  1996-03-15       Impact factor: 6.860

2.  Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study.

Authors:  Swathi Kaliki; Visweswaran Srinivasan; Adit Gupta; Dilip K Mishra; Milind N Naik
Journal:  Ophthalmology       Date:  2015-04-01       Impact factor: 12.079

3.  Machine Learning-based Analysis of Rectal Cancer MRI Radiomics for Prediction of Metachronous Liver Metastasis.

Authors:  Meng Liang; Zhengting Cai; Hongmei Zhang; Chencui Huang; Yankai Meng; Li Zhao; Dengfeng Li; Xiaohong Ma; Xinming Zhao
Journal:  Acad Radiol       Date:  2019-01-30       Impact factor: 3.173

Review 4.  Characterization of PET/CT images using texture analysis: the past, the present… any future?

Authors:  Mathieu Hatt; Florent Tixier; Larry Pierce; Paul E Kinahan; Catherine Cheze Le Rest; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-06       Impact factor: 9.236

5.  Assessment of early-stage optic nerve invasion in retinoblastoma using high-resolution 1.5 Tesla MRI with surface coils: a multicentre, prospective accuracy study with histopathological correlation.

Authors:  Hervé J Brisse; Pim de Graaf; Paolo Galluzzi; Kristel Cosker; Philippe Maeder; Sophia Göricke; Firazia Rodjan; Marcus C de Jong; Alexia Savignoni; Isabelle Aerts; Laurence Desjardins; Annette C Moll; Theodora Hadjistilianou; Paolo Toti; Paul van der Valk; Jonas A Castelijns; Xavier Sastre-Garau
Journal:  Eur Radiol       Date:  2014-11-30       Impact factor: 5.315

Review 6.  Diagnostic performance of magnetic resonance imaging and computed tomography for advanced retinoblastoma: a systematic review and meta-analysis.

Authors:  Marcus C de Jong; Pim de Graaf; Daniel P Noij; Sophia Göricke; Philippe Maeder; Paolo Galluzzi; Hervé J Brisse; Annette C Moll; Jonas A Castelijns
Journal:  Ophthalmology       Date:  2014-03-01       Impact factor: 12.079

7.  Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma.

Authors:  Ursula Winter; Daiana Ganiewich; Daniela Ottaviani; Santiago Zugbi; Rosario Aschero; Juan Martin Sendoya; Eduardo G Cafferata; Marcela Mena; Mariana Sgroi; Claudia Sampor; Fabiana Lubieniecki; Adriana Fandiño; Martin C Abba; François Doz; Osvaldo Podhjacer; Angel Montero Carcaboso; Eric Letouzé; François Radvanyi; Guillermo L Chantada; Andrea S Llera; Paula Schaiquevich
Journal:  JAMA Ophthalmol       Date:  2020-05-01       Impact factor: 7.389

Review 8.  Applications and limitations of radiomics.

Authors:  Stephen S F Yip; Hugo J W L Aerts
Journal:  Phys Med Biol       Date:  2016-06-08       Impact factor: 3.609

9.  Three-dimensional positron emission tomography image texture analysis of esophageal squamous cell carcinoma: relationship between tumor 18F-fluorodeoxyglucose uptake heterogeneity, maximum standardized uptake value, and tumor stage.

Authors:  Xinzhe Dong; Ligang Xing; Peipei Wu; Zheng Fu; Honglin Wan; Dengwang Li; Yong Yin; Xiaorong Sun; Jinming Yu
Journal:  Nucl Med Commun       Date:  2013-01       Impact factor: 1.690

10.  Survival with retinoblastoma in the USA: 1975-2004.

Authors:  E Broaddus; A Topham; A D Singh
Journal:  Br J Ophthalmol       Date:  2008-08-21       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.